Drugs / Histidine Tryptophan Ketoglutarate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02618824 Comparator | Dec 2015 → Aug 2016 | congenital heart disease | National Cardiovascular Center Harapan Kita Hospital Indonesia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Histidine Tryptophan Ketoglutarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02618824 ↗ |
| Known as | HTK | “Histidine Tryptophan Ketoglutarate (HTK) solution during cardiac operation.” NCT02618824 ↗ |